Inergetics Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2015 to a ratio of 7.05, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Inergetics Inc in Jun 30 2015 quarter, has decreased to 52 days, compared to 64 days, in the Mar 31 2015 quarter.

If we take a look into Healthcare sector 170 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2015 from 1135 to 2046.

What is Receivable Turnover Ratio?
What is Inergetics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NRTI Receivables Turnover Ratio	(Jun 30 2015) II. Quarter	(Mar 31 2015) I. Quarter	(Dec 31 2014) IV. Quarter	(Sep 30 2014) III. Quarter	(Jun 30 2014) II. Quarter
Y / Y Receivable Change	-71.48 %	-62.86 %	-27.46 %	-75.45 %	902.97 %
Y / Y Revenue Change	-61.78 %	-40.86 %	-2.28 %	111.58 %	685.42 %
Receivable Turnover Ratio (TTM)	7.05	5.74	5.49	5.07	3.2
NRTI's Total Ranking	# 2046	# 1135	# 2045	# 2045	# 2045
Accounts Receivable average collection period days	52	64	67	72	114
Seq. Receivable Change	40.34 %	-65.41 %	65.26 %	-64.46 %	82.8 %
Seq. Revenue Change	-29.49 %	-49.15 %	29.7 %	-17.83 %	9.13 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 63
Healthcare Sector	# 171
Overall Market	# 2046

Receivable Turnover Ratio Statistics
High	Average	Low
47.68	11.45	1.5
(Dec 31 2012)		(Sep 30 2013)

NRTI Company Profile • Back to NRTI Efficiency Comparisons • Compare NRTI Receivables Turnover Ratio to its Competitors

Financial Statements
Inergetics Inc's Accounts Receivable	$ 0 Millions	Visit NRTI's Balance sheet
Inergetics Inc's Sales TTM	$ 1 Millions	Visit NRTI's Income Statement
Sources of NRTI's Revenues		Visit NRTI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NRTI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NRTI's Growth Rates	NRTI's Roa	NRTI's Inventory Turnover Ratio	NRTI's Dividend Comparisons
NRTI's Profitability Ratios	NRTI's Roi	NRTI's Asset Turnover Ratio	NRTI's Dividend Growth
NRTI's Valuation Ratios	NRTI's Roe	NRTI's Financial Strength Ratios	NRTI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2015	Receivable at quarter ending Jun 30 2015
Ernexa Therapeutics Inc	23.38	$ 24.674 Millions	$ 1.055 Millions
Glucotrack Inc	22.79	$ 0.386 Millions	$ 0.017 Millions
U s Stem Cell Inc	21.50	$ 2.291 Millions	$ 0.107 Millions
Wearable Health Solutions, Inc.	21.49	$ 1.147 Millions	$ 0.053 Millions
Pacific Biosciences Of California Inc	21.34	$ 80.111 Millions	$ 3.753 Millions
Ardelyx inc	20.76	$ 37.962 Millions	$ 1.829 Millions
Ionis Pharmaceuticals Inc	20.65	$ 311.935 Millions	$ 15.104 Millions
Nektar Therapeutics	20.19	$ 283.884 Millions	$ 14.061 Millions
Aspira Women s Health inc	20.14	$ 3.378 Millions	$ 0.168 Millions
Vivosim Labs Inc	19.21	$ 0.778 Millions	$ 0.041 Millions
Tvardi Therapeutics Inc	18.05	$ 3.402 Millions	$ 0.189 Millions
Miragen Therapeutics Inc	17.81	$ 4.425 Millions	$ 0.249 Millions
Biocept Inc	17.69	$ 0.313 Millions	$ 0.018 Millions
Veracyte Inc	17.40	$ 45.163 Millions	$ 2.595 Millions
International Stem Cell Corporation	16.84	$ 7.217 Millions	$ 0.429 Millions
Cyclo Therapeutics Inc	16.21	$ 1.387 Millions	$ 0.086 Millions
Pacira Biosciences inc	16.02	$ 367.180 Millions	$ 22.919 Millions
Adma Biologics Inc	15.89	$ 7.228 Millions	$ 0.455 Millions
Sunlink Health Systems Inc	15.73	$ 85.285 Millions	$ 5.423 Millions
Harrow Inc	15.53	$ 4.521 Millions	$ 0.291 Millions
Gyre Therapeutics Inc	15.52	$ 1.071 Millions	$ 0.069 Millions
United Cannabis Corp	15.31	$ 0.589 Millions	$ 0.038 Millions
Epizyme Inc.	15.31	$ 20.173 Millions	$ 1.318 Millions
Acorda Therapeutics Inc	14.91	$ 437.391 Millions	$ 29.338 Millions
Apyx Medical Corp	14.80	$ 27.656 Millions	$ 1.869 Millions
Coherus Oncology inc	14.77	$ 35.221 Millions	$ 2.385 Millions
Caredx Inc	14.59	$ 28.951 Millions	$ 1.984 Millions
Ethema Health Corporation	14.44	$ 2.264 Millions	$ 0.157 Millions
Oncomed Pharmaceuticals Inc	14.23	$ 41.903 Millions	$ 2.945 Millions
Skinvisible Inc	14.11	$ 0.164 Millions	$ 0.012 Millions

Date modified: 2026-06-22T14:31:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.